Skip to main content
MedPathMedPath Home
Clinical Trials/ACTRN12619001573145
ACTRN12619001573145
Recruiting
Phase 1

Targeting the systemic inflammation associated with periodontitis to reduce risk in patients with coronary artery disease and on statin therapy- a randomized feasibility study

Western Sydney Local Health District0 sites60 target enrollmentNovember 14, 2019
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Not specified
Sponsor
Western Sydney Local Health District
Enrollment
60
Status
Recruiting
Last Updated
3 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
November 14, 2019
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • •have coronary artery disease
  • •\- hsCRP \>2mg/L
  • •\- have moderate\-severe periodontitis
  • •\- are currently on statin therapy

Exclusion Criteria

  • •Have received subgingival scaling and root planning in the last 6 months
  • •Are currently taking or have had antibiotic therapy in the last 3 months
  • •Are currently pregnant or planning pregnancy
  • •Are currently lactating/breastfeeding
  • •Have renal impairment
  • •Have hepatic impairment
  • •Have blood dyscrasias
  • •Are taking medications which interact with colchicine
  • •Have Type 1 Diabetes Mellitus
  • •Have moderate or severe periodontitis

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Not Applicable
prospective, observational registration studyfor women with Inflammatory breast cancerInflammatory Breast Cancer, INFLAME, IBC
NL-OMON28954BOOG (the PI of the study is from University Medical Center Groningen)200
Active, not recruiting
Phase 1
Application of intravenous lidocaïne and/or during surgery leads to a reduction of inflammation after breast cancer surgeryBreast cancer patients who undergo surgery for treatment.Therapeutic area: Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Anesthesia and Analgesia [E03]
EUCTR2012-002222-70-NLniversity Medical Centre St Radboud48
Completed
Phase 4
Pilot study: Targeting the inflammatory response and the induction of acute pain after breast cancer surgery with perioperative infusion of lidocaine
NL-OMON39927niversitair Medisch Centrum Sint Radboud16
Not yet recruiting
Not Applicable
Anti-inflammatory and immunomodulative effects of clarithromycin for severe septic patientssevere sepsis
JPRN-UMIN000021476Inoue laboratory, Tokai University30
Recruiting
Not Applicable
Anti-inflammatory and immunomodulative effects of human recombinant thrombomodulin for severe septic patients
JPRN-UMIN000018868Inoue's Labo in Tokai University45